22(S)-Hydroxycholesterol modulates the lipid and glucose metabolism by acting on liver X receptors. It has the potential to reduce lipogenesis and the accumulation of lipids in hepatocytes, myotubes and non-adipose tissue. 22-Hydroxycholesterol inhibits chemokine receptor activity.